Dr. Beldner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9313 Medical Plaza Dr Ste 103
North Charleston, SC 29406Phone+1 843-790-8280
Education & Training
- Medical University of South CarolinaFellowship, Hematology and Medical Oncology, 2004 - 2007
- Medical University of South CarolinaResidency, Internal Medicine, 2001 - 2004
- University of South Carolina School of MedicineClass of 2001
Certifications & Licensure
- SC State Medical License 2002 - 2025
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Regorafenib in Advanced Pancreatic Cancer Patients Start of enrollment: 2014 Jun 06
Publications & Presentations
PubMed
- 18 citationsCetuximab Combined With Induction Oxaliplatin and Capecitabine, Followed by Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: SWOG 0713Cynthia G. Leichman, Shannon McDonough, Stephen R. Smalley, Kevin G. Billingsley, Heinz-Josef Lenz
Clinical Colorectal Cancer. 2017-10-24 - 3 citationsPhase I dose escalation study of vinorelbine and topotecan combination chemotherapy in patients with recurrent lung cancerMatthew Beldner, Carol A. Sherman, Mark R. Green, Elizabeth Garrett-Mayer, Uzair B. Chaudhary
BMC Cancer. 2007-12-20 - 34 citationsLocalized palmar-plantar epidermal hyperplasia: a previously undefined dermatologic toxicity to sorafenib.Matthew Beldner, Michael A. Jacobson, Gene E. Burges, Deborah J. DeWaay, John C. Maize
The Oncologist. 2007-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: